Independent fund research. Built on SEC filings.

How we research funds

ETF · Health Care Sector · Oakmark (Harris)

Harbor Health Care ETF (MEDI)

Ticker MEDI · Since 2022-11-16 · · Holdings as of Jul 31, 2026

Expense ratio
0.8%$80/yr per $10k
1-yr return
+27.1%as of Dec 2025
Net assets
$41.2Mall share classes
Holdings
44

Bottom line

Is MEDI a good fund? The bottom line

MEDI is an actively managed health care sector ETF from Oakmark (Harris).

It charges 0.8% — about $80 a year on every $10,000 invested, cheaper than 61% of health care sector funds we track.

It returned +27.1% over one year (as of Dec 31, 2025, per its prospectus).

With $41.2 million in net assets and 44 holdings, its largest position is Eli Lilly & Co (20.8%) and the top 10 make up 59.7% of the portfolio.

What to watch

  • Concentrated: top 10 holdings are 59.7% of assets
  • Small fund ($41.2 million) — small funds are likelier to close
  • High turnover (167% a year) can mean more taxable distributions

Updated Nov 19, 2026

What MEDI invests in

The Fund seeks long-term growth of capital.

The Fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization. Under normal market conditions, the Fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry (health care companies). Health care companies may include, for example, manufacturers of health care equipment and supplies, health care services providers, pharmaceutical companies, biotechnology and life sciences companies, and suppliers of technologies for use by health care companies. The Fund may invest in issuers of all market capitalizations, including larger, established issuers and newer companies with little or no current revenues. The Fund may invest in foreign…

From the fund's prospectus (filed Feb 27, 2026).

MEDI performance

Fund calendar-year total returns, 2023–2025 2023: +24.8%; 2024: +0.5%; 2025: +27.1% +24.8% 2023 +0.5% 2024 +27.1% 2025
Fund gain (+)
Average annual total returns
1 yr5 yr10 yr
MEDI+27.1%——
Health Care Sector median+14.5%+4.2%+7.9%

Source: Fund prospectus, as of Dec 31, 2025

Full MEDI performance history →

What MEDI costs

On a $10,000 investment, MEDI's 0.8% expense ratio costs about $80 a year. The prospectus estimates $990 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.

See the full MEDI fee table →

MEDI top 10 holdings

#Holding% of fund
1Eli Lilly & Co20.78%
2Ascendis Pharma A/S13.61%
3Gilead Sciences Inc5.10%
4Rhythm Pharmaceuticals Inc4.02%
5AbbVie Inc3.09%
6Intuitive Surgical Inc2.83%
7Cencora Inc2.75%
8Revolution Medicines Inc2.54%
9Insmed Inc2.52%
10Merck & Co Inc2.47%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 59.7% of the fund. See all top 25 holdings and asset mix →

Alternatives to MEDI

More funds like MEDI →

MEDI FAQ

What is the expense ratio of MEDI?
MEDI's expense ratio is 0.8%, which works out to about $80 a year for every $10,000 invested. The prospectus estimates total costs of $990 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is MEDI a good investment?
It depends on your goals, but the data points to: concentrated: top 10 holdings are 59.7% of assets; small fund ($41.2 million) — small funds are likelier to close; high turnover (167% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does MEDI hold?
MEDI's largest holdings are Eli Lilly & Co (20.8%), Ascendis Pharma A/S (13.6%), Gilead Sciences Inc (5.1%), Rhythm Pharmaceuticals Inc (4.0%), AbbVie Inc (3.1%). It holds 44 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
Who manages MEDI?
MEDI is offered by Oakmark (Harris) through Harbor ETF Trust.